Bioabsorbable stents
William O’Neill, MD of Henry Ford discusses bioabsorbable coronary stents, and the U.S. Abbott trials. They devices are approved in Europe and being well adopted. Because the stent goes away, long-term anticoagulation is not required, and aneurysms are possibly less of a problem.
Cardiology/interventional, Henry Ford Hospital | apples49 | 
August 12, 2013 9:36 am
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
